WILLIS C. LEE - 26 Nov 2021 Form 4 Insider Report for Emmaus Life Sciences, Inc. (EMMA)

Role
Vice Chairman & COO, Director
Signature
Willis C. Lee
Issuer symbol
EMMA
Transactions as of
26 Nov 2021
Transactions value $
$81,612
Form type
4
Filing time
30 Nov 2021, 16:45:17 UTC
Previous filing
26 Nov 2021
Next filing
05 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EMMA Common stock, $0.001 par value Purchase $35.3K +24.3K +14.07% $1.45 197K 26 Nov 2021 By Fidelity Traditional IRA FBO Willis C. Lee F1
transaction EMMA Common stock, $0.001 par value Purchase $23.1K +15.7K +7.96% $1.47 213K 29 Nov 2021 By Fidelity Traditional IRA FBO Willis C. Lee F2
transaction EMMA Common stock, $0.001 par value Purchase $23.3K +15.5K +7.28% $1.50 228K 30 Nov 2021 By Fidelity Traditional IRA FBO Willis C. Lee F3
holding EMMA Common stock, $0.001 par value 256K 26 Nov 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.28 to $1.50, inclusive. The reporting person undertakes to provide to Emmaus Life Sciences, Inc., any security holder of Emmaus Life Sciences, Inc., and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote (1) and in footnotes (2) and (3) to this Form 4.
F2 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.38 to $1.50, inclusive.
F3 The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.39 to $1.53, inclusive.